Analyze Diet
Equine veterinary journal1986; 18(2); 133-137; doi: 10.1111/j.2042-3306.1986.tb03569.x

Four cases of traumatic optic nerve blindness in the horse.

Abstract: Traumatic optic nerve atrophy is characterised clinically by a unilateral or bilateral sudden onset of blindness. Dilated, fixed pupils and a lack of a menace reflex are the only abnormalities noted soon after the trauma. Within three to four weeks the optic disc becomes paler and the retinal vasculature is markedly decreased. The pathological lesion is a rupture of the nerve axons from stretching forces produced by the posterior movement of the brain against the fixed canalicular portion of the optic nerves. Medical therapy has not been successful.
Publication Date: 1986-03-01 PubMed ID: 3698952DOI: 10.1111/j.2042-3306.1986.tb03569.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study looks into instances of sudden blindness in horses due to trauma to the optic nerve, a condition known as traumatic optic nerve atrophy, detailing the symptoms, causes, and challenges of medical treatment.

Overview

This research article focuses on traumatic optic nerve atrophy, a severe vision impairment in horses, caused by traumatic injuries to the optic nerve. The study evaluates four different cases of this condition, detailing the clinical manifestations, causes, progression, and implications for treatment.

Clinical Characterisation

  • The study notes that this condition usually presents itself as an abrupt onset of unilateral or bilateral blindness. It’s often noticeable through specific clinical signs, including dilation and fixed pupils, as well as an absent menace response (a reflex blink in response to a perceived threat).

Progression

  • The researchers give a timeline of progression, observing that within three to four weeks after the trauma, the optic disc (the area where the optic nerve enters the eye) becomes noticeably paler.
  • Also, the amount of retinal vasculature (blood vessels in the retina) drastically decreases in these cases. Such changes suggest a significant disruption to vision-related structures.

Pathological Cause

  • The field’s underlying pathology lies in the nerve axons’ rupture, which are essential for transmitting visual information from the eye to the brain.
  • This rupture is often due to the posterior movement (backward movement) of the brain against the fixed canalicular portion of the optic nerves, causing the nerve axons to stretch and break.

Treatment Challenges

  • The researchers also touch on the challenges of treating this condition, pointing out that existing medical therapies have not been successful for cases of traumatic optic nerve atrophy.
  • Therefore, effective treatments for this vision-impairing condition are an area requiring more research and development.

Cite This Article

APA
Martin L, Kaswan R, Chapman W. (1986). Four cases of traumatic optic nerve blindness in the horse. Equine Vet J, 18(2), 133-137. https://doi.org/10.1111/j.2042-3306.1986.tb03569.x

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 18
Issue: 2
Pages: 133-137

Researcher Affiliations

Martin, L
    Kaswan, R
      Chapman, W

        MeSH Terms

        • Animals
        • Blindness / etiology
        • Blindness / pathology
        • Blindness / veterinary
        • Female
        • Horse Diseases / etiology
        • Horse Diseases / pathology
        • Horses
        • Male
        • Optic Nerve / pathology
        • Optic Nerve Injuries

        Grant Funding

        • 10-21-RRZ10-024 / NCRR NIH HHS